Skip to main content

Dopamine Receptor Genetics in Neuropsychiatric Disorders

Part of the The Receptors book series (REC)

Abstract

The dopamine system modulates a diverse set of neural functions relevant to neuropsychiatric disorders and is modulated by some drugs used to treat these conditions. As a result, dopamine receptor genes have been a major focus for genetic studies that have analyzed putative associations between polymorphic variants and a wide range of clinical syndromes including alcoholism, substance abuse, schizophrenia, ADHD, anxiety disorders, bipolar and unipolar mood disorders, as well as related traits thought to contribute to these syndromes. In the following chapter, we review the basic genetic organization of the dopamine receptor genes and the evidence for association with these diagnoses. There is considerable inconsistency in the results from these genetic association studies, which is consistent with a complex genetic phenotype, and the neurobiological complexity of behaviors affected in neuropsychiatric illness. Overall, the strongest findings are the associations between variation in the DRD2 gene and alcoholism and the DRD4 gene and ADHD. While these associations do not suggest a major effect on risk in most patients, they do provide important insights into the pathophysiology of these disorders.

Keywords

  • Dopamine
  • Receptor
  • Genes
  • Genetic association
  • SNP
  • Alcoholism
  • ADHD
  • Schizophrenia
  • Bipolar disorder
  • Substance abuse

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-60327-333-6_19
  • Chapter length: 48 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   269.00
Price excludes VAT (USA)
  • ISBN: 978-1-60327-333-6
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   349.99
Price excludes VAT (USA)
Hardcover Book
USD   349.99
Price excludes VAT (USA)
Fig. 19.1
Fig. 19.2
Fig. 19.3
Fig. 19.4
Fig. 19.5
Fig. 19.6

References

  1. Wong AH, Buckle CE, Van Tol HH. Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 2000;410:183–203.

    PubMed  CAS  CrossRef  Google Scholar 

  2. Lader M. Some adverse effects of antipsychotics: prevention and treatment. J Clin Psychiatry 1999;60(Suppl 12):18–21.

    PubMed  CAS  Google Scholar 

  3. Emilien G, Maloteaux JM, Geurts M, Hoogenberg K, Cragg S. Dopamine receptors – physiological understanding to therapeutic intervention potential. Pharmacol Ther 1999;84:133–56.

    PubMed  CAS  CrossRef  Google Scholar 

  4. American Psychiatric association. Diagnostics and Statistical Manual of Mental Disorders. 4th Edition, text revised. Washington, DC: American Psychiatric Association, 2000.

    Google Scholar 

  5. Wong AH, Gottesman, II, Petronis A. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum Mol Genet 2005;14 (Spec No. 1):R11–8.

    PubMed  CAS  CrossRef  Google Scholar 

  6. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347:146–51.

    PubMed  CAS  CrossRef  Google Scholar 

  7. Van Tol HH, Bunzow JR, Guan HC, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;350:610–4.

    PubMed  CrossRef  Google Scholar 

  8. Sunahara RK, Guan HC, O‘Dowd BF, et al. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991;350:614–9.

    PubMed  CAS  CrossRef  Google Scholar 

  9. Tiberi M, Jarvie KR, Silvia C, et al. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci USA 1991;88:7491–5.

    PubMed  CAS  CrossRef  Google Scholar 

  10. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979;277:93–6.

    PubMed  CAS  CrossRef  Google Scholar 

  11. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993;33:281–307.

    PubMed  CAS  CrossRef  Google Scholar 

  12. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993;16:299–321.

    PubMed  CAS  CrossRef  Google Scholar 

  13. Jackson DM, Westlind-Danielsson A. Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994;64:291–370.

    PubMed  CAS  CrossRef  Google Scholar 

  14. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15:264–70.

    PubMed  CAS  CrossRef  Google Scholar 

  15. Sokoloff P, Schwartz JC. Novel dopamine receptors half a decade later. Trends Pharmacol Sci 1995;16:270–5.

    PubMed  CAS  CrossRef  Google Scholar 

  16. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev 1998;78:189–225.

    PubMed  CAS  Google Scholar 

  17. Dal Toso R, Sommer B, Ewert M, et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 1989;8:4025–34.

    PubMed  CAS  Google Scholar 

  18. Giros B, Sokoloff P, Martres MP, Riou JF, Emorine LJ, Schwartz JC. Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 1989;342:923–6.

    PubMed  CAS  CrossRef  Google Scholar 

  19. Monsma FJ, Jr., McVittie LD, Gerfen CR, Mahan LC, Sibley DR. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 1989;342:926–9.

    PubMed  CAS  CrossRef  Google Scholar 

  20. Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 2000;24:125–32.

    PubMed  CAS  CrossRef  Google Scholar 

  21. Fishburn CS, Belleli D, David C, Carmon S, Fuchs S. A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. J Biol Chem 1993;268:5872–8.

    PubMed  CAS  Google Scholar 

  22. Giros B, Martres MP, Pilon C, Sokoloff P, Schwartz JC. Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochem Biophys Res Commun 1991;176:1584–92.

    PubMed  CAS  CrossRef  Google Scholar 

  23. Snyder LA, Roberts JL, Sealfon SC. Alternative transcripts of the rat and human dopamine D3 receptor. Biochem Biophys Res Commun 1991;180:1031–5.

    PubMed  CAS  CrossRef  Google Scholar 

  24. Grandy DK, Marchionni MA, Makam H, et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 1989;86:9762–6.

    PubMed  CAS  CrossRef  Google Scholar 

  25. Weinshank RL, Adham N, Macchi M, Olsen MA, Branchek TA, Hartig PR. Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene. J Biol Chem 1991;266:22427–35.

    PubMed  CAS  Google Scholar 

  26. Castro SW, Strange PG. Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor. J Neurochem 1993;60:372–5.

    PubMed  CAS  CrossRef  Google Scholar 

  27. Malmberg A, Jackson DM, Eriksson A, Mohell N. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol 1993;43:749–54.

    PubMed  CAS  Google Scholar 

  28. Senogles SE. The D2 s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 2000;58:455–62.

    PubMed  CAS  Google Scholar 

  29. Senogles SE. D2 s dopamine receptor mediates phospholipase D and antiproliferation. Mol Cell Endocrinol 2003;209:61–9.

    PubMed  CAS  CrossRef  Google Scholar 

  30. Grandy DK, Zhou QY, Allen L, et al. A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. Am J Hum Genet 1990;47:828–34.

    PubMed  CAS  Google Scholar 

  31. Zhou QY, Li C, Civelli O. Characterization of gene organization and promoter region of the rat dopamine D1 receptor gene. J Neurochem 1992;59:1875–83.

    PubMed  CAS  CrossRef  Google Scholar 

  32. Liu Q, Sobell JL, Heston LL, Sommer SS. Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence changes. Am J Med Genet 1995;60:165–71.

    PubMed  CAS  CrossRef  Google Scholar 

  33. Cichon S, Nothen MM, Stober G, et al. Systematic screening for mutations in the 5'-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 1996;67:424–8.

    PubMed  CAS  CrossRef  Google Scholar 

  34. Kojima H, Ohmori O, Shinkai T, Terao T, Suzuki T, Abe K. Dopamine D1 receptor gene polymorphism and schizophrenia in Japan. Am J Med Genet 1999;88:116–9.

    PubMed  CAS  CrossRef  Google Scholar 

  35. Ni X, Trakalo JM, Mundo E, et al. Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder. Biol Psychiatry 2002;52:1144–50.

    PubMed  CAS  CrossRef  Google Scholar 

  36. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, et al. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 2006;53:46–50.

    PubMed  CAS  CrossRef  Google Scholar 

  37. Del Zompo M, De Luca V, Severino G, et al. Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia. Am J Med Genet B Neuropsychiatr Genet 2007;144:237–41.

    Google Scholar 

  38. Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005;134:37–8.

    Google Scholar 

  39. Rybakowski JK, Borkowska A, Czerski PM, Kapelski P, Dmitrzak-Weglarz M, Hauser J. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia. J Neural Transm 2005;112:1575–82.

    PubMed  CAS  CrossRef  Google Scholar 

  40. Misener VL, Luca P, Azeke O, et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry 2004;9:500–9.

    PubMed  CAS  CrossRef  Google Scholar 

  41. Limosin F, Loze JY, Rouillon F, Ades J, Gorwood P. Association between dopamine receptor D1 gene DdeI polymorphism and sensation seeking in alcohol-dependent men. Alcohol Clin Exp Res 2003;27:1226–8.

    PubMed  CAS  CrossRef  Google Scholar 

  42. Kim DJ, Park BL, Yoon S, et al. 5' UTR polymorphism of dopamine receptor D1 (DRD1) associated with severity and temperament of alcoholism. Biochem Biophys Res Commun 2007;357:1135–41.

    PubMed  CAS  CrossRef  Google Scholar 

  43. Maron E, Nikopensius T, Koks S, et al. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 2005;15:17–24.

    PubMed  CrossRef  Google Scholar 

  44. Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol 2006;9:167–74.

    PubMed  CAS  CrossRef  Google Scholar 

  45. Grandy DK, Litt M, Allen L, et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989;45:778–85.

    PubMed  CAS  Google Scholar 

  46. Pohjalainen T, Rinne JO, Nagren K, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998;3:256–60.

    PubMed  CAS  CrossRef  Google Scholar 

  47. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997;7:479–84.

    PubMed  CAS  CrossRef  Google Scholar 

  48. Barr CL, Kidd KK. Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 1993;34:204–9.

    PubMed  CAS  CrossRef  Google Scholar 

  49. Cravchik A, Sibley DR, Gejman PV. Functional analysis of the human D2 dopamine receptor missense variants. J Biol Chem 1996;271:26013–7.

    PubMed  CAS  CrossRef  Google Scholar 

  50. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003;12:205–16.

    PubMed  CAS  CrossRef  Google Scholar 

  51. Luo HR, Hou ZF, Wu J, Zhang YP, Wan YJ. Evolution of the DRD2 gene haplotype and its association with alcoholism in Mexican Americans. Alcohol 2005;36:117–25.

    PubMed  CAS  CrossRef  Google Scholar 

  52. Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990;263:2055–60.

    PubMed  CAS  CrossRef  Google Scholar 

  53. Amadeo S, Abbar M, Fourcade ML, et al. D2 dopamine receptor gene and alcoholism. J Psychiatr Res 1993;27:173–9.

    PubMed  CAS  CrossRef  Google Scholar 

  54. Arinami T, Itokawa M, Komiyama T, et al. Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese. Biol Psychiatry 1993;33:108–14.

    PubMed  CAS  CrossRef  Google Scholar 

  55. Ishiguro H, Arinami T, Saito T, et al. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 1998;22:845–8.

    PubMed  CAS  Google Scholar 

  56. Connor JP, Young RM, Lawford BR, Ritchie TL, Noble EP. D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence. Eur Psychiatry 2002;17:17–23.

    PubMed  CAS  CrossRef  Google Scholar 

  57. Kono Y, Yoneda H, Sakai T, et al. Association between early-onset alcoholism and the dopamine D2 receptor gene. Am J Med Genet 1997;74:179–82.

    PubMed  CAS  CrossRef  Google Scholar 

  58. Gorwood P, Batel P, Gouya L, Courtois F, Feingold J, Ades J. Reappraisal of the association between the DRD2 gene, alcoholism and addiction. Eur Psychiatry 2000;15:90–6.

    PubMed  CAS  CrossRef  Google Scholar 

  59. Gorwood P, Limosin F, Batel P, Duaux E, Gouya L, Ades J. The genetics of addiction: alcohol-dependence and D3 dopamine receptor gene. Pathol Biol (Paris) 2001;49:710–7.

    CAS  CrossRef  Google Scholar 

  60. Sander T, Ladehoff M, Samochowiec J, Finckh U, Rommelspacher H, Schmidt LG. Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol Clin Exp Res 1999;23:578–81.

    PubMed  CAS  CrossRef  Google Scholar 

  61. Goldman D, Brown GL, Albaugh B, et al. DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 1993;17:199–204.

    PubMed  CAS  CrossRef  Google Scholar 

  62. Foley PF, Loh EW, Innes DJ, et al. Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann NY Acad Sci 2004;1025:39–46.

    PubMed  CAS  CrossRef  Google Scholar 

  63. Cruz C, Camarena B, Mejia JM, et al. The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population. Arch Med Res 1995;26:421–6.

    PubMed  CAS  Google Scholar 

  64. Chen CH, Chien SH, Hwu HG. Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan. Am J Med Genet 1996;67:488–90.

    PubMed  CAS  CrossRef  Google Scholar 

  65. Goldman D, Urbanek M, Guenther D, Robin R, Long JC. A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse. Alcohol 1998;16:47–52.

    PubMed  CAS  CrossRef  Google Scholar 

  66. Lu RB, Ko HC, Chang FM, et al. No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biol Psychiatry 1996;39:419–29.

    PubMed  CAS  CrossRef  Google Scholar 

  67. Edenberg HJ, Foroud T, Koller DL, et al. A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. Alcohol Clin Exp Res 1998;22:505–12.

    PubMed  CAS  CrossRef  Google Scholar 

  68. Samochowiec J, Kucharska-Mazur J, Grzywacz A, et al. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett 2006;410:1–5.

    PubMed  CAS  CrossRef  Google Scholar 

  69. Blum K, Noble EP, Sheridan PJ, et al. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. Alcohol 1993;10:59–67.

    PubMed  CAS  CrossRef  Google Scholar 

  70. Konishi T, Calvillo M, Leng AS, Lin KM, Wan YJ. Polymorphisms of the dopamine D2 receptor, serotonin transporter, and GABA(A) receptor beta(3) subunit genes and alcoholism in Mexican-Americans. Alcohol 2004;32:45–52.

    PubMed  CAS  CrossRef  Google Scholar 

  71. Finckh U, Rommelspacher H, Schmidt LG, Rolfs A. Allele-specific PCR for simultaneous amplification of both alleles of a deletion polymorphism in intron 6 of the human dopamine 2 receptor gene (DRD2). DNA Seq 1996;6:87–94.

    PubMed  CAS  Google Scholar 

  72. Finckh U, von Widdern O, Giraldo-Velasquez M, et al. No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism. Alcohol Clin Exp Res 1996;20:528–32.

    PubMed  CAS  CrossRef  Google Scholar 

  73. Parsian A, Cloninger CR, Zhang ZH. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am J Med Genet 2000;96:407–11.

    PubMed  CAS  CrossRef  Google Scholar 

  74. Gejman PV, Ram A, Gelernter J, et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 1994;271:204–8.

    PubMed  CAS  CrossRef  Google Scholar 

  75. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004;23:540–5.

    PubMed  CAS  CrossRef  Google Scholar 

  76. Pato CN, Macciardi F, Pato MT, Verga M, Kennedy JL. Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Am J Med Genet 1993;48:78–82.

    PubMed  CAS  CrossRef  Google Scholar 

  77. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007;12:454–61.

    PubMed  CAS  Google Scholar 

  78. Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol 2008;167:125–38.

    PubMed  CrossRef  Google Scholar 

  79. Kaneshima M, Higa T, Nakamoto H, Nagamine M. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin Neurosci 1997;51:379–81.

    PubMed  CAS  CrossRef  Google Scholar 

  80. Chen CH, Chien SH, Hwu HG. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Am J Med Genet 1996;67:418–20.

    PubMed  CAS  CrossRef  Google Scholar 

  81. Laurent C, Bodeau-Pean S, Campion D, et al. No major role for the dopamine D2 receptor Ser–>Cys311 mutation in schizophrenia. Psychiatr Genet 1994;4:229–30.

    PubMed  CAS  CrossRef  Google Scholar 

  82. Dubertret C, Gouya L, Hanoun N, et al. The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 2004;67:75–85.

    PubMed  CrossRef  Google Scholar 

  83. Vijayan NN, Bhaskaran S, Koshy LV, et al. Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behav Brain Funct 2007;3:34.

    PubMed  CrossRef  CAS  Google Scholar 

  84. Glatt SJ, Faraone SV, Tsuang MT. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 2003;8:911–5.

    PubMed  CAS  CrossRef  Google Scholar 

  85. Glatt SJ, Jonsson EG. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet 2006;141:149–54.

    Google Scholar 

  86. Levinson DF. Meta-analysis in psychiatric genetics. Curr Psychiatry Rep 2005;7:143–51.

    PubMed  CrossRef  Google Scholar 

  87. Jonsson EG, Sillen A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2003;119B:28–34.

    PubMed  CrossRef  Google Scholar 

  88. Hanninen K, Katila H, Kampman O, et al. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci Lett 2006;407:195–8.

    PubMed  CrossRef  CAS  Google Scholar 

  89. Lawford BR, Young RM, Swagell CD, et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr Res 2005;73:31–7.

    PubMed  CrossRef  Google Scholar 

  90. Hoenicka J, Aragues M, Rodriguez-Jimenez R, et al. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr Scand 2006;114:435–8.

    PubMed  CAS  CrossRef  Google Scholar 

  91. Kukreti R, Tripathi S, Bhatnagar P, et al. Association of DRD2 gene variant with schizophrenia. Neurosci Lett 2006;392:68–71.

    PubMed  CAS  CrossRef  Google Scholar 

  92. Meta-Analysis of All Published Schizophrenia-Association Studies (Case-Control Only) rs6277. Schizophrenia Research Forum, 2005–2008. (Accessed July 2, 2008, at http://www.schizophreniaforum.org/res/sczgene/meta.asp?geneID=93)

  93. Breen G, Brown J, Maude S, et al. -141 C del/ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. Am J Med Genet 1999;88:407–10.

    PubMed  CAS  CrossRef  Google Scholar 

  94. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997;6:577–82.

    PubMed  CAS  CrossRef  Google Scholar 

  95. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 2001;49:203–12.

    PubMed  CAS  CrossRef  Google Scholar 

  96. Glatt SJ, Faraone SV, Tsuang MT. DRD2 -141C insertion/deletion polymorphism is not associated with schizophrenia: results of a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2004;128:21–3.

    CrossRef  Google Scholar 

  97. Li T, Arranz M, Aitchison KJ, et al. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophr Res 1998;32:87–92.

    PubMed  CAS  CrossRef  Google Scholar 

  98. Ambrosio AM, Kennedy JL, Macciardi F, et al. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population. Psychiatry Res 2004;125:185–91.

    PubMed  CAS  CrossRef  Google Scholar 

  99. Parsons MJ, Mata I, Beperet M, et al. A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 2007;17:159–63.

    PubMed  CrossRef  Google Scholar 

  100. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2 Ser/Cys311 and -141C Ins/Del polymorphisms. Psychiatry Clin Neurosci 2002;56:97–102.

    PubMed  CAS  CrossRef  Google Scholar 

  101. Sarkar G, Kapelner S, Grandy DK, et al. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 1991;11:8–14.

    PubMed  CAS  CrossRef  Google Scholar 

  102. Craddock N, Roberts Q, Williams N, McGuffin P, Owen MJ. Association study of bipolar disorder using a functional polymorphism (Ser311–>Cys) in the dopamine D2 receptor gene. Psychiatr Genet 1995;5:63–5.

    PubMed  CAS  CrossRef  Google Scholar 

  103. Kirov G, Jones I, McCandless F, Craddock N, Owen MJ. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5. Mol Psychiatry 1999;4:558–65.

    PubMed  CAS  CrossRef  Google Scholar 

  104. Furlong RA, Coleman TA, Ho L, et al. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders. Am J Med Genet 1998;81:385–7.

    PubMed  CAS  CrossRef  Google Scholar 

  105. Gorwood P, Bellivier F, Ades J, Leboyer M. The DRD2 gene and the risk for alcohol dependence in bipolar patients. Eur Psychiatry 2000;15:103–8.

    PubMed  CAS  CrossRef  Google Scholar 

  106. Li T, Liu X, Sham PC, et al. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Res 1999;86:193–201.

    PubMed  CAS  CrossRef  Google Scholar 

  107. Serretti A, Lattuada E, Lorenzi C, Lilli R, Smeraldi E. Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol Psychiatry 2000;5:270–4.

    PubMed  CAS  CrossRef  Google Scholar 

  108. Lawford BR, Young RM, Noble EP, et al. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 2000;96:592–8.

    PubMed  CAS  CrossRef  Google Scholar 

  109. Conner BT, Noble EP, Berman SM, et al. DRD2 genotypes and substance use in adolescent children of alcoholics. Drug Alcohol Depend 2005;79:379–87.

    PubMed  CAS  CrossRef  Google Scholar 

  110. Xu K, Lichtermann D, Lipsky RH, et al. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 2004;61:597–606.

    PubMed  CAS  CrossRef  Google Scholar 

  111. Smith SS, O‘Hara BF, Persico AM, et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992;49:723–7.

    PubMed  CAS  CrossRef  Google Scholar 

  112. Gelernter J, Kranzler H, Satel SL. No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans. Biol Psychiatry 1999;45:340–5.

    PubMed  CAS  CrossRef  Google Scholar 

  113. Crocq MA, Mant R, Asherson P, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992;29:858–60.

    PubMed  CAS  CrossRef  Google Scholar 

  114. Gene Overview of All Published Schizophrenia-Association Studies for DRD3. Schizophrenic Research Forum, 2005–2008. (Accessed July 2, 2008, at http://www.schizophreniaforum.org/res/sczgene/geneoverview.asp?geneid=224)

  115. Joober R, Toulouse A, Benkelfat C, et al. DRD3 and DAT1 genes in schizophrenia: an association study. J Psychiatr Res 2000;34:285–91.

    PubMed  CAS  CrossRef  Google Scholar 

  116. Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1997;74:40–3.

    PubMed  CAS  CrossRef  Google Scholar 

  117. Jonsson EG, Flyckt L, Burgert E, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 2003;13:1–12.

    PubMed  CrossRef  Google Scholar 

  118. Virgos C, Martorell L, Valero J, et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res 2001;49:65–71.

    PubMed  CAS  CrossRef  Google Scholar 

  119. Rietschel M, Nothen MM, Albus M, et al. Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases. Schizophr Res 1996;20:181–6.

    PubMed  CAS  CrossRef  Google Scholar 

  120. Rothschild LG, Badner J, Cravchik A, Gershon ES, Gejman PV. No association detected between a D3 receptor gene-expressed variant and schizophrenia. Am J Med Genet 1996;67:232–4.

    PubMed  CAS  CrossRef  Google Scholar 

  121. Nanko S, Sasaki T, Fukuda R, et al. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum Genet 1993;92:336–8.

    PubMed  CAS  CrossRef  Google Scholar 

  122. Lorenzo CV, Baca-Garcia E, Hernandez MD, et al. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample. Am J Med Genet B Neuropsychiatr Genet 2007;144:344–6.

    Google Scholar 

  123. Dominguez E, Loza MI, Padin F, et al. Extensive linkage disequilibrium mapping at HTR2A and DRD3 for schizophrenia susceptibility genes in the Galician population. Schizophr Res 2007;90:123–9.

    PubMed  CrossRef  Google Scholar 

  124. Laurent C, Savoye C, Samolyk D, et al. Homozygosity at the dopamine D3 receptor locus is not associated with schizophrenia. J Med Genet 1994;31:260.

    PubMed  CAS  CrossRef  Google Scholar 

  125. Tanaka T, Igarashi S, Onodera O, et al. Association study between schizophrenia and dopamine D3 receptor gene polymorphism. Am J Med Genet 1996;67:366–8.

    PubMed  CAS  CrossRef  Google Scholar 

  126. Fathalli F, Rouleau GA, Xiong L, et al. No association between the DRD3 Ser9Gly polymorphism and schizophrenia. Schizophr Res 2008;98:98–104.

    PubMed  CrossRef  Google Scholar 

  127. Kremer I, Rietschel M, Dobrusin M, et al. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. Am J Med Genet 2000;96:778–80.

    PubMed  CAS  CrossRef  Google Scholar 

  128. Staddon S, Arranz MJ, Mancama D, et al. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr Res 2005;73:49–54.

    PubMed  CrossRef  Google Scholar 

  129. Ishiguro H, Okuyama Y, Toru M, Arinami T. Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia. Mol Psychiatry 2000;5:433–8.

    PubMed  CAS  CrossRef  Google Scholar 

  130. Kennedy JL, Billett EA, Macciardi FM, et al. Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1995;60:558–62.

    PubMed  CAS  CrossRef  Google Scholar 

  131. Sivagnanasundaram S, Morris AG, Gaitonde EJ, McKenna PJ, Mollon JD, Hunt DM. A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia. Neurosci Lett 2000;279:13–6.

    PubMed  CAS  CrossRef  Google Scholar 

  132. Jonsson EG, Kaiser R, Brockmoller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 2004;14:9–12.

    PubMed  CrossRef  Google Scholar 

  133. Parsian A, Chakraverty S, Todd RD. Possible association between the dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 1995;60:234–7.

    PubMed  CAS  CrossRef  Google Scholar 

  134. Elvidge G, Jones I, McCandless F, Asherson P, Owen MJ, Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis. Am J Med Genet 2001;105:307–11.

    PubMed  CAS  CrossRef  Google Scholar 

  135. Van Den Bogaert A, Sleegers K, De Zutter S, et al. No allelic association or interaction of three known functional polymorphisms with bipolar disorder in a northern Swedish isolated population. Psychiatr Genet 2006;16:209–12.

    CrossRef  Google Scholar 

  136. Barr CL, Wigg KG, Wu J, et al. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2000;96:114–7.

    PubMed  CAS  CrossRef  Google Scholar 

  137. Higuchi S, Muramatsu T, Matsushita S, Murayama M. No evidence of association between structural polymorphism at the dopamine D3 receptor locus and alcoholism in the Japanese. Am J Med Genet 1996;67:412–4.

    PubMed  CAS  CrossRef  Google Scholar 

  138. Parsian A, Chakraverty S, Fisher L, Cloninger CR. No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism. Am J Med Genet 1997;74:281–5.

    PubMed  CAS  CrossRef  Google Scholar 

  139. Lee MS, Ryu SH. No association between the dopamine D3 receptor gene and Korean alcohol dependence. Psychiatr Genet 2002;12:173–6.

    PubMed  CrossRef  Google Scholar 

  140. Gorwood P, Martres MP, Ades J, et al. Lack of association between alcohol-dependence and D3 dopamine receptor gene in three independent samples. Am J Med Genet 1995;60:529–31.

    PubMed  CAS  CrossRef  Google Scholar 

  141. Duaux E, Gorwood P, Griffon N, et al. Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry 1998;3:333–6.

    PubMed  CAS  CrossRef  Google Scholar 

  142. Comings DE, Gonzalez N, Wu S, et al. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol Psychiatry 1999;4:484–7.

    PubMed  CAS  CrossRef  Google Scholar 

  143. Krebs MO, Sautel F, Bourdel MC, et al. Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry 1998;3:337–41.

    PubMed  CAS  CrossRef  Google Scholar 

  144. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 1996;98:91–101.

    PubMed  CAS  CrossRef  Google Scholar 

  145. Ebstein RP, Novick O, Umansky R, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996;12:78–80.

    PubMed  CAS  CrossRef  Google Scholar 

  146. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet 1996;12:81–4.

    PubMed  CAS  CrossRef  Google Scholar 

  147. Kluger AN, Siegfried Z, Ebstein RP. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol Psychiatry 2002;7:712–7.

    PubMed  CAS  CrossRef  Google Scholar 

  148. Asghari V, Schoots O, van Kats S, et al. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol 1994;46:364–73.

    PubMed  CAS  Google Scholar 

  149. Jovanovic V, Guan HC, Van Tol HH. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics 1999;9:561–8.

    PubMed  CAS  CrossRef  Google Scholar 

  150. Seaman MI, Fisher JB, Chang F, Kidd KK. Tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4). Am J Med Genet 1999;88:705–9.

    PubMed  CAS  CrossRef  Google Scholar 

  151. Mitsuyasu H, Kawasaki H, Ninomiya H, et al. Genetic structure of the dopamine receptor D4 gene (DRD4) and lack of association with schizophrenia in Japanese patients. J Psychiatr Res 2007;41:763–75.

    PubMed  CrossRef  Google Scholar 

  152. Mitsuyasu H, Ozawa H, Takeda Y, Fukumaki Y. Novel polymorphisms in the upstream region of the human dopamine D4 receptor (DRD4) gene. J Hum Genet 1999;44:416–8.

    PubMed  CAS  CrossRef  Google Scholar 

  153. Kamakura S, Iwaki A, Matsumoto M, Fukumaki Y. Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene. Biochem Biophys Res Commun 1997;235:321–6.

    PubMed  CAS  CrossRef  Google Scholar 

  154. Okuyama Y, Ishiguro H, Toru M, Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 1999;258:292–5.

    PubMed  CAS  CrossRef  Google Scholar 

  155. Catalano M, Nobile M, Novelli E, Nothen MM, Smeraldi E. Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry 1993;34:459–64.

    PubMed  CAS  CrossRef  Google Scholar 

  156. Cichon S, Nothen MM, Catalano M, et al. Identification of two novel polymorphisms and a rare deletion variant in the human dopamine D4 receptor gene. Psychiatr Genet 1995;5:97–103.

    PubMed  CAS  CrossRef  Google Scholar 

  157. Eisenberg J, Zohar A, Mei-Tal G, et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet 2000;96:258–61.

    PubMed  CAS  CrossRef  Google Scholar 

  158. Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet 2000;96:268–72.

    PubMed  CAS  CrossRef  Google Scholar 

  159. Bakker SC, van der Meulen EM, Oteman N, et al. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am J Med Genet B Neuropsychiatr Genet 2005;132:50–2.

    Google Scholar 

  160. Cheuk DK, Li SY, Wong V. Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children. Am J Med Genet B Neuropsychiatr Genet 2006;141:907–11.

    Google Scholar 

  161. Carrasco X, Rothhammer P, Moraga M, et al. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet B Neuropsychiatr Genet 2006;141:51–4.

    Google Scholar 

  162. Leung PW, Lee CC, Hung SF, et al. Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet 2005;133:54–6.

    Google Scholar 

  163. Barkley RA, Smith KM, Fischer M, Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet 2006;141:487–98.

    Google Scholar 

  164. Mill J, Curran S, Kent L, et al. Attention deficit hyperactivity disorder (ADHD) and the dopamine D4 receptor gene: evidence of association but no linkage in a UK sample. Mol Psychiatry 2001;6:440–4.

    PubMed  CAS  CrossRef  Google Scholar 

  165. Bellgrove MA, Hawi Z, Lowe N, Kirley A, Robertson IH, Gill M. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am J Med Genet B Neuropsychiatr Genet 2005;136:81–6.

    Google Scholar 

  166. El-Faddagh M, Laucht M, Maras A, Vohringer L, Schmidt MH. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J Neural Transm 2004;111:883–9.

    PubMed  CAS  CrossRef  Google Scholar 

  167. Grady DL, Chi HC, Ding YC, et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry 2003;8:536–45.

    PubMed  CAS  CrossRef  Google Scholar 

  168. Brookes K, Xu X, Chen W, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 2006;11:934–53.

    PubMed  CAS  CrossRef  Google Scholar 

  169. Faraone SV, Biederman J, Weiffenbach B, et al. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 1999;156:768–70.

    PubMed  CAS  Google Scholar 

  170. Gornick MC, Addington A, Shaw P, et al. Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update. Am J Med Genet B Neuropsychiatr Genet 2007;144:379–82.

    Google Scholar 

  171. Kotler M, Manor I, Sever Y, et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet 2000;96:278–81.

    PubMed  CAS  CrossRef  Google Scholar 

  172. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000;5:396–404.

    PubMed  CAS  CrossRef  Google Scholar 

  173. Smalley SL, Bailey JN, Palmer CG, et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:427–30.

    PubMed  CAS  CrossRef  Google Scholar 

  174. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry 2001;6:429–33.

    PubMed  CAS  CrossRef  Google Scholar 

  175. Arcos-Burgos M, Castellanos FX, Konecki D, et al. Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate. Mol Psychiatry 2004;9:252–9.

    PubMed  CAS  CrossRef  Google Scholar 

  176. Swanson JM, Sunohara GA, Kennedy JL, et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998;3:38–41.

    PubMed  CAS  CrossRef  Google Scholar 

  177. Rowe DC, Stever C, Giedinghagen LN, et al. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:419–26.

    PubMed  CAS  CrossRef  Google Scholar 

  178. Langley K, Marshall L, van den Bree M, et al. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 2004;161:133–8.

    PubMed  CrossRef  Google Scholar 

  179. Qian Q, Wang Y, Li J, Yang L, Wang B, Zhou R. Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder. Beijing Da Xue Xue Bao 2003;35:412–8.

    PubMed  CAS  Google Scholar 

  180. Qian Q, Wang Y, Zhou R, Yang L, Faraone SV. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder. Am J Med Genet B Neuropsychiatr Genet 2004;128:84–9.

    CrossRef  Google Scholar 

  181. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006;15:2276–84.

    PubMed  CAS  CrossRef  Google Scholar 

  182. Bhaduri N, Das M, Sinha S, et al. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am J Med Genet B Neuropsychiatr Genet 2006;141:61–6.

    Google Scholar 

  183. Kereszturi E, Kiraly O, Csapo Z, et al. Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses. Am J Med Genet B Neuropsychiatr Genet 2007;144:231–6.

    Google Scholar 

  184. Guan LL, Wang YF, Li J, Wang B, Yang L, Qian QJ. Association analysis of dopamine D4 receptor gene polymorphism and attention deficit hyperactivity disorder with/without disruptive behavior disorder. Beijing Da Xue Xue Bao 2007;39:233–6.

    PubMed  CAS  Google Scholar 

  185. McCracken JT, Smalley SL, McGough JJ, et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:531–6.

    PubMed  CAS  CrossRef  Google Scholar 

  186. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002;12:207–15.

    PubMed  CrossRef  Google Scholar 

  187. Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001;158:1052–7.

    PubMed  CAS  CrossRef  Google Scholar 

  188. Weiss J, Magert HJ, Cieslak A, Forssmann WG. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Eur J Med Res 1996;1:439–45.

    PubMed  CAS  Google Scholar 

  189. Zhang ML, Yuan GZ, Yao JJ, et al. Associations between six functional genes and schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003;20:69–71.

    PubMed  CAS  Google Scholar 

  190. Tang Y, Wang Y, Cai Z. Schizophrenia and dopamine D4 gene polymorphism in Chinese population: association analysis. Zhonghua Yi Xue Za Zhi 2001;81:995–8.

    PubMed  CAS  Google Scholar 

  191. Aguirre AJ, Apiquian R, Fresan A, Cruz-Fuentes C. Association analysis of exon III and exon I polymorphisms of the dopamine D4 receptor locus in Mexican psychotic patients. Psychiatry Res 2007;153:209–15.

    PubMed  CAS  CrossRef  Google Scholar 

  192. Lung FW, Chen N, Shu BC. Dopamine D4 receptor gene and the -521C>T polymorphism of the upstream region of the dopamine D4 receptor gene in schizophrenia. Psychiatr Genet 2006;16:139–43.

    PubMed  CrossRef  Google Scholar 

  193. Hong CJ, Lee YL, Sim CB, Hwu HG. Dopamine D4 receptor variants in Chinese sporadic and familial schizophrenics. Am J Med Genet 1997;74:412–5.

    PubMed  CAS  CrossRef  Google Scholar 

  194. Kaiser R, Konneker M, Henneken M, et al. Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol Psychiatry 2000;5:418–24.

    PubMed  CAS  CrossRef  Google Scholar 

  195. Barr CL, Kennedy JL, Lichter JB, et al. Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. Am J Med Genet 1993;48:218–22.

    PubMed  CAS  CrossRef  Google Scholar 

  196. Kohn Y, Ebstein RP, Heresco-Levy U, et al. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur Neuropsychopharmacol 1997;7:39–43.

    PubMed  CAS  CrossRef  Google Scholar 

  197. Ambrosio AM, Kennedy JL, Macciardi F, et al. No evidence of association or linkage disequilibrium between polymorphisms in the 5' upstream and coding regions of the dopamine D4 receptor gene and schizophrenia in a Portuguese population. Am J Med Genet B Neuropsychiatr Genet 2004;125:20–4.

    CrossRef  Google Scholar 

  198. Shaikh S, Gill M, Owen M, et al. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1994;54:8–11.

    PubMed  CAS  CrossRef  Google Scholar 

  199. Petronis A, Macciardi F, Athanassiades A, et al. Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1995;60:452–5.

    PubMed  CAS  CrossRef  Google Scholar 

  200. Lung FW, Tzeng DS, Shu BC. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. Schizophr Res 2002;57:239–45.

    PubMed  CrossRef  Google Scholar 

  201. Glatt SJ, Faraone SV, Tsuang MT. Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis. Biol Psychiatry 2003;54:629–35.

    PubMed  CAS  CrossRef  Google Scholar 

  202. Mitsuyasu H, Hirata N, Sakai Y, et al. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene (DRD4) with schizophrenia and personality traits. J Hum Genet 2001;46:26–31.

    PubMed  CAS  CrossRef  Google Scholar 

  203. Golimbet VE, Gritsenko IK, Alfimova MV, et al. Dopamine receptor DRD4 gene polymorphism and its association with schizophrenia spectrum disorders and personality traits of patients. Zh Nevrol Psikhiatr Im S S Korsakova 2005;105:42–7.

    PubMed  CAS  Google Scholar 

  204. Xing QH, Wu SN, Lin ZG, et al. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia. Schizophr Res 2003;65:9–14.

    PubMed  CrossRef  Google Scholar 

  205. Jonsson EG, Ivo R, Forslund K, et al. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. Am J Med Genet 2001;105:525–8.

    PubMed  CAS  CrossRef  Google Scholar 

  206. Paterson AD, Ying DJ, Petronis A, et al. A PstI restriction fragment length polymorphism in the 5' untranslated region of DRD4 is not associated with schizophrenia. Psychiatr Genet 1996;6:191–3.

    PubMed  CAS  CrossRef  Google Scholar 

  207. Jonsson EG, Sedvall GC, Nothen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophr Res 2003;61:111–9.

    PubMed  CrossRef  Google Scholar 

  208. Bocchetta A, Piccardi MP, Palmas MA, Chillotti C, Oi A, Del Zompo M. Family-based association study between bipolar disorder and DRD2, DRD4, DAT, and SERT in Sardinia. Am J Med Genet 1999;88:522–6.

    PubMed  CAS  CrossRef  Google Scholar 

  209. Lim LC, Nothen MM, Korner J, et al. No evidence of association between dopamine D4 receptor variants and bipolar affective disorder. Am J Med Genet 1994;54:259–63.

    PubMed  CAS  CrossRef  Google Scholar 

  210. Muglia P, Petronis A, Mundo E, Lander S, Cate T, Kennedy JL. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol Psychiatry 2002;7:860–6.

    PubMed  CAS  CrossRef  Google Scholar 

  211. Chang FM, Ko HC, Lu RB, Pakstis AJ, Kidd KK. The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: six polymorphisms tested separately and as haplotypes. Biol Psychiatry 1997;41:394–405.

    PubMed  CAS  CrossRef  Google Scholar 

  212. Ishiguro H, Saito T, Shibuya H, Arinami T. Association study between genetic polymorphisms in the 14-3-3 eta chain and dopamine D4 receptor genes and alcoholism. Alcohol Clin Exp Res 2000;24:343–7.

    PubMed  CAS  Google Scholar 

  213. George SR, Cheng R, Nguyen T, Israel Y, O‘Dowd BF. Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Commun 1993;196:107–14.

    PubMed  CAS  CrossRef  Google Scholar 

  214. Franke P, Nothen MM, Wang T, et al. DRD4 exon III VNTR polymorphism-susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach. Mol Psychiatry 2000;5:101–4.

    PubMed  CAS  CrossRef  Google Scholar 

  215. Li T, Xu K, Deng H, et al. Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry 1997;2:413–6.

    PubMed  CAS  CrossRef  Google Scholar 

  216. Kotler M, Cohen H, Segman R, et al. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 1997;2:251–4.

    PubMed  CAS  CrossRef  Google Scholar 

  217. Szilagyi A, Boor K, Szekely A, et al. Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence. Neuropsychopharmacol Hung 2005;7:28–33.

    PubMed  Google Scholar 

  218. Munafo MR, Yalcin B, Willis-Owen SA, Flint J. Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data. Biol Psychiatry 2008;63:197–206.

    PubMed  CAS  CrossRef  Google Scholar 

  219. Sherrington R, Mankoo B, Attwood J, et al. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. Genomics 1993;18:423–5.

    PubMed  CAS  CrossRef  Google Scholar 

  220. Asherson P, Mant R, Williams N, et al. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 1998;3:310–20.

    PubMed  CAS  CrossRef  Google Scholar 

  221. Sobell JL, Lind TJ, Sigurdson DC, et al. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet 1995;4:507–14.

    PubMed  CAS  CrossRef  Google Scholar 

  222. Muir WJ, Thomson ML, McKeon P, et al. Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder. Am J Med Genet 2001;105:152–8.

    PubMed  CAS  CrossRef  Google Scholar 

  223. Barr CL, Wigg KG, Feng Y, et al. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mol Psychiatry 2000;5:548–51.

    PubMed  CAS  CrossRef  Google Scholar 

  224. Mill J, Curran S, Richards S, Taylor E, Asherson P. Polymorphisms in the dopamine D5 receptor (DRD5) gene and ADHD. Am J Med Genet B Neuropsychiatr Genet 2004;125:38–42.

    CrossRef  Google Scholar 

  225. Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999;4:192–6.

    PubMed  CAS  CrossRef  Google Scholar 

  226. Manor I, Corbex M, Eisenberg J, et al. Association of the dopamine D5 receptor with attention deficit hyperactivity disorder (ADHD) and scores on a continuous performance test (TOVA). Am J Med Genet B Neuropsychiatr Genet 2004;127:73–7.

    CrossRef  Google Scholar 

  227. Lowe N, Kirley A, Hawi Z, et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am J Hum Genet 2004;74:348–56.

    PubMed  CAS  CrossRef  Google Scholar 

  228. Kalsi G, Sherrington R, Mankoo BS, et al. Linkage study of the D5 dopamine receptor gene (DRD5) in multiplex Icelandic and English schizophrenia pedigrees. Am J Psychiatry 1996;153:107–9.

    PubMed  CAS  Google Scholar 

  229. Gorwood P, Genetic association studies in behavioral neuroscience. In: Cruzio W, Gerlai R, eds., Molecular Genetic Techniques for Behavioural Neuroscience. Amsterdam: Elsevier, 1999:113–21.

    Google Scholar 

  230. Xing Q, Qian X, Li H, et al. The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 2007;10:631–7.

    PubMed  CAS  CrossRef  Google Scholar 

  231. Mihara K, Kondo T, Suzuki A, et al. Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene. Psychopharmacology (Berl) 2000;149:246–50.

    CAS  CrossRef  Google Scholar 

  232. Steen VM, Lovlie R, MacEwan T, McCreadie RG. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry 1997;2:139–45.

    PubMed  CAS  CrossRef  Google Scholar 

  233. Bakker PR, van Harten PN, van Os J. Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis. Schizophr Res 2006;83:185–92.

    PubMed  CrossRef  Google Scholar 

  234. Chong SA, Tan EC, Tan CH, Mythily, Chan YH. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003;116B:51–4.

    Google Scholar 

  235. Lattuada E, Cavallaro R, Serretti A, Lorenzi C, Smeraldi E. Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment. Int J Neuropsychopharmacol 2004;7:489–93.

    PubMed  CAS  CrossRef  Google Scholar 

  236. Noble EP, St Jeor ST, Ritchie T, et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 1994;42:257–60.

    PubMed  CAS  CrossRef  Google Scholar 

  237. Limosin F, Gorwood P, Loze JY, et al. Male limited association of the dopamine receptor D2 gene TaqI a polymorphism and alcohol dependence. Am J Med Genet 2002;112:343–6.

    PubMed  CrossRef  Google Scholar 

  238. Konishi T, Luo HR, Calvillo M, Mayo MS, Lin KM, Wan YJ. ADH1B*1, ADH1C*2, DRD2 (-141C Ins), and 5-HTTLPR are associated with alcoholism in Mexican American men living in Los Angeles. Alcohol Clin Exp Res 2004;28:1145–52.

    PubMed  CAS  CrossRef  Google Scholar 

  239. O‘Hara BF, Smith SS, Bird G, et al. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered 1993;43:209–18.

    PubMed  CrossRef  Google Scholar 

  240. Noble EP, Zhang X, Ritchie TL, Sparkes RS. Haplotypes at the DRD2 locus and severe alcoholism. Am J Med Genet 2000;96:622–31.

    PubMed  CAS  CrossRef  Google Scholar 

  241. Sasabe T, Furukawa A, Matsusita S, Higuchi S, Ishiura S. Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients. Neurosci Lett 2007;412:139–42.

    PubMed  CAS  CrossRef  Google Scholar 

  242. Freimer M, Kranzler H, Satel S, et al. No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict Biol 1996;1:281–7.

    PubMed  CAS  CrossRef  Google Scholar 

  243. Szekeres G, Keri S, Juhasz A, et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004;124:1–5.

    CrossRef  Google Scholar 

  244. Baritaki S, Rizos E, Zafiropoulos A, et al. Association between schizophrenia and DRD3 or HTR2 receptor gene variants. Eur J Hum Genet 2004;12:535–41.

    PubMed  CAS  CrossRef  Google Scholar 

  245. Chiaroni P, Azorin JM, Dassa D, et al. Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder. Psychiatr Genet 2000;10:43–9.

    PubMed  CAS  CrossRef  Google Scholar 

  246. Tsai SJ, Cheng CY, Shu LR, et al. No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatr Genet 2002;12:29–33.

    PubMed  CrossRef  Google Scholar 

  247. Hong CJ, Chiu HJ, Chang YS, Sim CB. Twelve-nucleotide repeat polymorphism of D4 dopamine receptor gene in Chinese familial schizophrenic patients. Biol Psychiatry 1998;43:432–5.

    PubMed  CAS  CrossRef  Google Scholar 

  248. Serretti A, Lilli R, Di Bella D, et al. Dopamine receptor D4 gene is not associated with major psychoses. Am J Med Genet 1999;88:486–91.

    PubMed  CAS  CrossRef  Google Scholar 

  249. Seeman P, Ulpian C, Chouinard G, et al. Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. Am J Med Genet 1994;54:384–90.

    PubMed  CAS  CrossRef  Google Scholar 

  250. Nothen MM, Cichon S, Hemmer S, et al. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet 1994;3:2207–12.

    PubMed  CAS  CrossRef  Google Scholar 

  251. Vanyukov MM, Moss HB, Gioio AE, Hughes HB, Kaplan BB, Tarter RE. An association between a microsatellite polymorphism at the DRD5 gene and the liability to substance abuse: pilot study. Behav Genet 1998;28:75–82.

    PubMed  CAS  CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Albert H.C. Wong .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lee, F.H., Wong, A.H. (2010). Dopamine Receptor Genetics in Neuropsychiatric Disorders. In: Neve, K. (eds) The Dopamine Receptors. The Receptors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-333-6_19

Download citation